by tumor type the best responses were obtained in lymphomas ( 8/31 cr + pr ) , uterus ( 2/9 ) , prostate ( 1/5 ) , rhabdomyosarcoma ( 2/6 ) , neuroblastoma ( 2/4 ) , colon/rectum ( 5/81 ) , other gastrointestinal ( 4/32 ) .
C2981607
tumor type
C0027819
neuroblastoma